BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19769073)

  • 1. [HAART influences the lipids].
    Behrens G
    MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein CIII and highly active antiretroviral therapy (HAART)-induced hypertriglyceridemia.
    Badiou S; Dupuy AM; Baillat V; Fabre J; Tur MD; Cristol JP; Reynes J
    Clin Lab; 2003; 49(1-2):11-3. PubMed ID: 12593470
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trial.
    Gavrila A; Hsu W; Tsiodras S; Doweiko J; Gautam S; Martin L; Moses AC; Karchmer AW; Mantzoros CS
    Clin Infect Dis; 2005 Mar; 40(5):745-9. PubMed ID: 15714423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating antiretroviral-induced dyslipidemia in HIV-infected adults.
    Scordo KA
    Nurse Pract; 2010 Jul; 35(7):32-7; quiz 37-8. PubMed ID: 20555242
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates.
    Manfredi R
    Int J STD AIDS; 2010 Jan; 21(1):73-4. PubMed ID: 19843616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Also consider cardiovascular risk. Every HIV patient "his" HAART].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():58-60. PubMed ID: 19031565
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 10. Strange side effects.
    TreatmentUpdate; 2002 Nov; 14(8):3. PubMed ID: 12501821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of dyslipidemia in HIV-infected patients].
    Moog AM; Becker W
    MMW Fortschr Med; 2012 May; 154 Suppl 1():34-6. PubMed ID: 22916597
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV, HAART and dentistry: what you need to know.
    O'Halloran M; Hogan J; Flint SR
    J Ir Dent Assoc; 2006; 52(1):18-22. PubMed ID: 16830835
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.
    Ware LJ; Jackson AG; Wootton SA; Burdge GC; Morlese JF; Moyle GJ; Jackson AA; Gazzard BG
    Br J Nutr; 2009 Oct; 102(7):1038-46. PubMed ID: 19480729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiology patient page. The metabolic syndrome.
    Lennie TA
    Circulation; 2006 Oct; 114(15):e528-9. PubMed ID: 17030691
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report.
    Muise A; Arbess G
    Int J STD AIDS; 2001 Sep; 12(9):612-3. PubMed ID: 11516372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
    Young J; Glass TR; Bernasconi E; Rickenbach M; Furrer H; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC;
    J Clin Epidemiol; 2009 Jun; 62(6):632-41. PubMed ID: 19108985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concerns about myocardial infarction risk.
    AIDS Patient Care STDS; 2005 Apr; 19(4):274. PubMed ID: 15918235
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
    Sabin CA
    J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiretroviral treatment of HIV infected patients].
    Lichterfeld M; Rockstroh JK
    Med Monatsschr Pharm; 2003 Apr; 26(4):111-21; quiz 121-2. PubMed ID: 12722525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.